Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017 Publisher



Lui M1 ; Safiri S2, 3, 4 ; Mereke A5 ; Davletov K5 ; Mebonia N6 ; Myrkassymova A7 ; Aripov T8 ; Mirrakhimov E9, 10 ; Aghayan SA11 ; Gamkrelidze A12 ; Naghavi M13 ; Kopec JA1 ; Sarrafzadegan N1, 14
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Population & Public Health, University of British Columbia, Vancouver, Canada
  2. 2. Tuberculosis and Lung Disease Research Center, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Health Research Institute, The Faculty of Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan
  6. 6. Department of Epidemiology and Biostatistics, Tbilisi State Medical University, Tbilisi, Georgia
  7. 7. School of Public Health, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  8. 8. Department of Public Health and Healthcare Management, Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan
  9. 9. Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  10. 10. National Center of Cardiology and Internal Disease, Bishkek, Kyrgyzstan
  11. 11. Department of Zoology, Yerevan State University, Yerevan, Armenia
  12. 12. National Center for Disease Control and Public Health, Tbilisi, Georgia
  13. 13. Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Washington, United States
  14. 14. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: IJC Heart and Vasculature Published:2021


Abstract

Background: The burden of ischemic heart disease (IHD) is high. There is limited information on the burden of IHD in identified high risk areas like Central Asia (CA) which is comprised of Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Turkmenistan, Mongolia, Uzbekistan and Tajikistan. This study addresses the burden of IHD in CA at the regional and country levels. Methods: Using data from the latest iteration of the Global Burden of Disease Study (GBD), this study provides age-adjusted mortality, prevalence, and Disability Adjusted Life Years (DALYs) of IHD by sex in the CA region, and national levels for countries in this region from 1990 to 2017. Results: The CA region has a higher IHD burden than the rest of the world over the studied period. Amongst the countries within this region, age-standardized mortality and DALY rates in Uzbekistan are the highest not only in CA but worldwide, while Armenia consistently has the lowest IHD burden in CA. Unhealthy diet, high systolic blood pressure and LDL-cholesterol are the risk factors with the highest attributable IHD DALYs. Conclusion: Increasing burden of IHD over time in CA can be partially explained by the economic crisis in the 1990s. There is considerable variation in IHD DALY rates among countries in the CA region. The reasons for such differences are likely multifactorial such as differences in risk factors distribution, health care effectiveness, political, social and economic factors. © 2021
Other Related Docs
25. Prevalence of Total Cholesterol in Iran: Systematic Review and Meta-Analysis, Journal of Mazandaran University of Medical Sciences (2015)
27. Socioeconomic Inequality in Congenital Heart Diseases in Iran, International Journal for Equity in Health (2021)
34. Trend of Atherosclerosis Risk Factors in Children of Isfahan, Asian Cardiovascular and Thoracic Annals (2001)
39. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
42. Dietary Patterns in Relation to Lipid Profiles Among Iranian Adults, Journal of Cardiovascular and Thoracic Research (2019)